Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

SHEZF is undervalued

OTC · Healthcare

FAIR PRICE

61.8%upside

Updated daily

Model: DCF 50% · Relative 30% · Consensus 20%

$0.47

MARKET PRICE

$0.76

FAIR PRICE

$0.29

MARGIN

UNDERFAIROVER

COMMUNITY BUY ZONE

UNLOCKS AT 10

Where does the market buy SHEZF?

No one has priced SHEZF yet — be the first. Every investor sets the maximum price they'd still buy at; together that maps the community buy zone.

COMMUNITY MEDIAN

▓▓▓▓▓

BUYERS AT TODAY'S PRICE

▓▓ %

0/10 INVESTORS · 10 MORE TO UNLOCK

METRICS

P/E–
P/B–
P/S–
PEG–
DIV YIELD–
ROE–
ROIC–
DEBT/EQ–
MKT CAPN/A

NOW AVAILABLE

Get notified when SHEZF's fair price changes

Push notifications when SHEZF's valuation shifts. Available on iOS and Android.

Download on the App StoreGet it on Google Play

MARGIN OF SAFETY

A 20% margin of safety below fair value — the conservative entry level for risk-aware investors.

$0.61CONSERVATIVE ENTRY
$0.76FAIR PRICE
$0.47MARKET PRICE

SAFETY MARGIN

20%

Below fair value

ENTRY LEVEL

$0.61

Fair price × 0.80

DISTANCE

29.5%

Price to entry level

At the current price of $0.47, SHEZF trades 29.5% below the conservative entry level of $0.61. The stock is currently priced below the 20% margin of safety threshold, indicating a potential value opportunity based on the model.

Margin of safety is a risk management concept, not an investment recommendation. The 20% threshold follows Benjamin Graham's value investing framework. Fair price and entry levels are model-based estimates updated daily. Learn more about Margin of Safety ↗

VALUATION HISTORY

SYNCING FEED ▌

P/E RATIO HISTORY

SYNCING FEED ▌

METHODOLOGY

How we calculate SHEZF's fair price

Shenzhen Hepalink Pharmaceutical Group Co., Ltd.'s fair price of $0.76 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $0.47, SHEZF trades 61.8% below its calculated fair value.

DCF MODEL · 50%

Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting SHEZF's risk profile.

RELATIVE · 30%

Comparing SHEZF's valuation multiples against Healthcare peers to determine if the stock is over or undervalued relative to its industry.

ANALYST · 20%

Aggregated analyst price targets for SHEZF, weighted by recency and analyst accuracy.

TRY IT YOURSELF

Want to test your own assumptions? Use our free calculators to estimate SHEZF's fair value with your own inputs.

LEARN MORE

Bulios

POWERED BY BULIOS

Get full analysis, financials, and AI insights for SHEZF.

Explore on Bulios

FAQ

What is the fair price of SHEZF?+

Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. is $0.76. At the current market price of $0.47, SHEZF trades 61.8% below its calculated fair value.

Is SHEZF overvalued or undervalued?+

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. is currently undervalued based on our valuation model. The stock trades at $0.47, which is 61.8% below the fair price of $0.76.

What is the margin of safety for SHEZF?+

With a 20% margin of safety applied to the fair price of $0.76, the conservative entry level for SHEZF is $0.61. At the current market price of $0.47, the stock trades 29.5% below this entry level. Margin of safety is a risk management concept from Benjamin Graham's value investing framework, not an investment recommendation.

How often is SHEZF's fair price updated?+

We update fair price calculations for SHEZF daily after market close. The current fair price of $0.76 incorporates the latest market data and sector multiples.

What factors affect SHEZF's fair price calculation?+

SHEZF's fair price of $0.76 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight)..

Is SHEZF a good buy right now?+

At $0.47, SHEZF trades 61.8% below our fair value estimate of $0.76. The stock is currently undervalued. Fair Price Index provides valuation data — always do your own research before investing.

Does SHEZF pay dividends?+

SHEZF does not currently pay a dividend.

RELATED STOCKS

Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.